Literature DB >> 12921720

Detection of equine herpesvirus-1 in the fetal membranes of aborted equine fetuses by immunohistochemical and in-situ hybridization techniques.

L Szeredi1, H Aupperle, K Steiger.   

Abstract

Formalin-fixed, paraffin wax-embedded fetal membranes from 76 cases of equine abortion were examined immunohistochemically for equine herpesvirus (EHV)-1 antigen. Of the 76 cases, 11 had been proved EHV-1-positive by diagnostic methods applied to the aborted fetuses (viral isolation in tissue culture, or immunohistochemical examination, or both). Of the 11 fetal membranes from the virus-positive animals, five gave positive results on immunohistochemical examination, and three on in-situ hybridization; the positive signals were detected in trophoblastic cells and occasionally in monocytes and endothelial cells. The distribution of virus appeared to be related to areas of (1) vacuolar degeneration and desquamation of chorionic epithelium, (2) mild lympho-histiocytic vasculitis and placentitis, and (3) increased metabolic activity of mesenchymal cells in the villi of the fetal membranes. This is the first report of EHV-1 antigen and nucleic acid detection in the trophoblasts of fetal membranes from spontaneous cases of equine abortion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12921720     DOI: 10.1016/s0021-9975(03)00022-7

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  2 in total

1.  Equid herpesvirus type 1 activates platelets.

Authors:  Tracy Stokol; Wee Ming Yeo; Deborah Burnett; Nicole DeAngelis; Teng Huang; Nikolaus Osterrieder; James Catalfamo
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

2.  Equid herpesvirus 1 and rhodococcus equi coinfection in a foal with bronchointerstitial pneumonia.

Authors:  Alejandro Perez-Ecija; Francisco Javier Mendoza; José Carlos Estepa; María José Bautista; José Pérez
Journal:  J Vet Med Sci       Date:  2016-06-03       Impact factor: 1.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.